Combination antifungal therapy

被引：401

作者：

Johnson, MD

MacDougall, C

Ostrosky-Zeichner, L

Perfect, JR

Rex, JH

机构：

[1] Duke Univ, Med Ctr, Dept Med, Div Infect Dis, Durham, NC 27710 USA

[2] Duke Univ, Med Ctr, Dept Pharm, Durham, NC 27710 USA

[3] Campbell Univ, Sch Pharm, Buies Creek, NC 27506 USA

[4] Univ Texas, Houston Med Sch, Ctr Study Emerging Reemerging Pathogens, Dept Internal Med,Div Infect Dis, Houston, TX USA

[5] AstraZeneca, Macclesfield, Cheshire, England

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2004年 / 48卷 / 03期

关键词：

D O I：

10.1128/AAC.48.3.693-715.2004

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：693 / 715

页数：23

共 224 条

[81] Utility of 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenyl-amino)carbonyl]-2H-tetrazolium hydroxide (XTT) and minimum effective concentration assays in the determination of antifungal susceptibility of Aspergillus fumigatus to the lipopeptide class of compounds [J].

Hawser, SP ;

Jessup, C ;

Vitullo, J ;

Ghannoum, MA .

JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (07) :2738-2741

[82] Prospective screening by a panfungal polymerase chain reaction assay in patients at risk for fungal infections:: implications for the management of febrile neutropenia [J].

Hebart, H ;

Löffler, J ;

Reitze, H ;

Engel, A ;

Schumacher, U ;

Klingebiel, T ;

Bader, P ;

Böhme, A ;

Martin, H ;

Bunjes, D ;

Kern, WV ;

Kanz, L ;

Einsele, H .

BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (02) :635-640

[83] Early detection of Aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening [J].

Hebart, H ;

Löffler, J ;

Meisner, C ;

Serey, F ;

Schmidt, D ;

Böhme, A ;

Martin, H ;

Engel, A ;

Bunjes, D ;

Kern, WV ;

Schumacher, U ;

Kanz, L ;

Einsele, H .

JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (05) :1713-1719

[84] Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients [J].

Herbrecht, R ;

Letscher-Bru, V ;

Oprea, C ;

Lioure, B ;

Waller, J ;

Campos, F ;

Villard, O ;

Liu, KL ;

Natarajan-Amé, S ;

Lutz, P ;

Dufour, P ;

Bergerat, JP ;

Candolfi, E .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (07) :1898-1906

[85] Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis [J].

Herbrecht, R ;

Denning, DW ;

Patterson, TF ;

Bennett, JE ;

Greene, RE ;

Oestmann, JW ;

Kern, WV ;

Marr, KA ;

Ribaud, P ;

Lortholary, O ;

Sylvester, R ;

Rubin, RH ;

Wingard, JR ;

Stark, P ;

Durand, C ;

Caillot, D ;

Thiel, E ;

Chandrasekar, PH ;

Hodges, MR ;

Schlamm, HT ;

Troke, PF ;

de Pauw, B .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (06) :408-415

[86] INVITRO ACTIVITIES OF AMPHOTERICIN-B IN COMBINATION WITH 4 ANTIFUNGAL AGENTS AND RIFAMPIN AGAINST ASPERGILLUS SPP [J].

HUGHES, CE ;

HARRIS, C ;

MOODY, JA ;

PETERSON, LR ;

GERDING, DN .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (05) :560-562

[87] Candida fungemia in neonates treated with fluconazole:: report of forty cases, including eight with meningitis [J].

Huttova, M ;

Hartmanova, I ;

Kralinsky, K ;

Filka, J ;

Uher, J ;

Kurak, J ;

Krizan, S ;

Krcmery, V .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (11) :1012-1015

[88] Itraconazole and flucytosine plus itraconazole combination in the treatment of experimental cryptococcosis in hamsters [J].

Iovannitti, C ;

Negroni, R ;

Bava, J ;

Finquelievich, J ;

Kral, M .

MYCOSES, 1995, 38 (11-12) :449-452

[89] USE OF COMBINATIONS OF ANTIMICROBIAL DRUGS [J].

JAWETZ, E .

ANNUAL REVIEW OF PHARMACOLOGY, 1968, 8 :151-+

[90] A randomized comparative study to determine the effect of omeprazole on the peak serum concentration of itraconazole oral solution [J].

Johnson, MD ;

Hamilton, CD ;

Drew, RH ;

Sanders, LL ;

Pennick, GJ ;

Perfect, JR .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (02) :453-457

← 4 5 6 7 8 9 10 11 12 13 →